Sacrococcygeal Teratoma prognosis

The prognosis for Sacrococcygeal Teratoma (SCT) is generally favorable, especially when diagnosed prenatally and managed with timely surgical intervention. While outcomes depend heavily on tumor size, vascularity, and the timing of resection, the majority of infants treated for Sacrococcygeal Teratoma go on to lead healthy lives, though long-term monitoring is essential for identifying potential late-onset complications.

How does prognosis vary by subtype and timing?

The prognosis for Sacrococcygeal Teratoma is most favorable when the tumor is detected early via fetal ultrasound. The Altman classification system is used to categorize the tumor based on its external and internal components. Tumors that are primarily external (Type I) generally have a better prognosis than those with significant internal (pelvic or abdominal) extension. Early detection allows for fetal intervention if hydrops fetalis—a life-threatening condition involving fluid accumulation—develops, which significantly improves survival rates for high-risk Sacrococcygeal Teratoma cases.

What factors influence long-term health?

Success in treating Sacrococcygeal Teratoma relies on a multi-disciplinary approach. Key factors that improve outcomes include:

• Complete surgical resection of the tumor, including the coccyx, to minimize the risk of recurrence.


• Early identification and management of fetal complications, such as high-output heart failure.


• Regular follow-up appointments to monitor for tumor markers like alpha-fetoprotein (AFP).


• Coordinated care between pediatric surgeons, urologists, and oncologists.

What are the long-term complications to monitor?

While surgical survival rates for Sacrococcygeal Teratoma are high, survivors may face long-term challenges. These include bowel and bladder dysfunction, such as constipation or neurogenic bladder, due to the tumor's proximity to pelvic nerves. Furthermore, there is a small but recognized risk of recurrence, necessitating periodic screenings. With 40 members in our DiseaseMaps community, we see firsthand that proactive, specialized care is the cornerstone of maximizing quality of life for those living with the aftereffects of Sacrococcygeal Teratoma.

Next steps

• Consult with a pediatric surgical oncologist to establish a long-term surveillance schedule.


• Join the DiseaseMaps.org community to connect with other families navigating the post-treatment journey.


• Keep a detailed medical record of all imaging and AFP lab results for transition into adult care.

Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Portal for rare diseases and orphan drugs


• Children’s Oncology Group (COG) guidelines on germ cell tumors


• Journal of Pediatric Surgery: Long-term outcomes in Sacrococcygeal Teratoma